- Home
- DNN vs CDTX Comparison
DNN vs CDTX Comparison
Compare DNN & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNN
- CDTX
- Stock Information
- Founded
- DNN 1954
- CDTX 2012
- Country
- DNN Canada
- CDTX United States
- Employees
- DNN N/A
- CDTX N/A
- Industry
- DNN Other Metals and Minerals
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DNN Basic Materials
- CDTX Health Care
- Exchange
- DNN Nasdaq
- CDTX Nasdaq
- Market Cap
- DNN 1.8B
- CDTX 1.6B
- IPO Year
- DNN 1997
- CDTX 2015
- Fundamental
- Price
- DNN $2.85
- CDTX $101.51
- Analyst Decision
- DNN Strong Buy
- CDTX Strong Buy
- Analyst Count
- DNN 1
- CDTX 11
- Target Price
- DNN $2.75
- CDTX $91.60
- AVG Volume (30 Days)
- DNN 98.5M
- CDTX 1.2M
- Earning Date
- DNN 11-06-2025
- CDTX 11-06-2025
- Dividend Yield
- DNN N/A
- CDTX N/A
- EPS Growth
- DNN N/A
- CDTX N/A
- EPS
- DNN N/A
- CDTX N/A
- Revenue
- DNN $3,311,190.00
- CDTX N/A
- Revenue This Year
- DNN $197.76
- CDTX N/A
- Revenue Next Year
- DNN $54.87
- CDTX N/A
- P/E Ratio
- DNN N/A
- CDTX N/A
- Revenue Growth
- DNN 12.14
- CDTX N/A
- 52 Week Low
- DNN $1.08
- CDTX $10.14
- 52 Week High
- DNN $2.97
- CDTX $106.63
- Technical
- Relative Strength Index (RSI)
- DNN 68.96
- CDTX 73.64
- Support Level
- DNN $2.70
- CDTX $96.35
- Resistance Level
- DNN $2.93
- CDTX $106.63
- Average True Range (ATR)
- DNN 0.15
- CDTX 6.77
- MACD
- DNN -0.01
- CDTX 1.87
- Stochastic Oscillator
- DNN 75.00
- CDTX 87.48
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.